processing...

Choose a analysis:

Hint: You can either select all, or use ctrl + select to choose multiple

Check the experimental factors of this study in the table below. The first column is grouped (combined) factors and subsequent columns are individual factors

sample_sourcecombined_factorsSource_Name[gating]TreatmentBatchNote
1Bone marrowSource_Name[gating]:Lineage-negative (Lin<U+2013>) | Treatment:[13C, 15N] AAs were incorporated for 1 h | Batch:1a | Note:[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).Source_Name[gating]:Lineage-negative (Lin<U+2013>)[13C, 15N] AAs were incorporated for 1 h1a[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).
2Bone marrowSource_Name[gating]:Lineage-negative (Lin<U+2013>) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Lineage-negative (Lin<U+2013>)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
3Bone marrowSource_Name[gating]:Lineage-negative (Lin<U+2013>) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Lineage-negative (Lin<U+2013>)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
4Bone marrowSource_Name[gating]:Lineage-negative (Lin<U+2013>) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Lineage-negative (Lin<U+2013>)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
5Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC) | Treatment:[13C, 15N] AAs were incorporated for 1 h | Batch:1a | Note:[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC)[13C, 15N] AAs were incorporated for 1 h1a[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).
6Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC) | Treatment:HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC)HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).
7Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC) | Treatment:HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC)HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).
8Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC) | Treatment:HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ CD48<U+2013> CD150+ (HSC)HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).
9Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK) | Treatment:[13C, 15N] AAs were incorporated for 1 h | Batch:1a | Note:[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK)[13C, 15N] AAs were incorporated for 1 h1a[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).
10Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
11Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
12Bone marrowSource_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Lin<U+2013> Scal1+ c-Kit+ (LSK)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
13Bone marrowSource_Name[gating]:Mature hematopoietic cells (Lin+ cells) | Treatment:[13C, 15N] AAs were incorporated for 1 h | Batch:1a | Note:[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).Source_Name[gating]:Mature hematopoietic cells (Lin+ cells)[13C, 15N] AAs were incorporated for 1 h1a[13C, 15N] AAs were used for AA uptake (Fig1.B); unlabeled AAs were used for total AA (Fig1.A) and TCA substrate levels (Fig1.D).
14Bone marrowSource_Name[gating]:Mature hematopoietic cells (Lin+ cells) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Mature hematopoietic cells (Lin+ cells)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
15Bone marrowSource_Name[gating]:Mature hematopoietic cells (Lin+ cells) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Mature hematopoietic cells (Lin+ cells)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).
16Bone marrowSource_Name[gating]:Mature hematopoietic cells (Lin+ cells) | Treatment:[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | Batch:1b | Note:[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).Source_Name[gating]:Mature hematopoietic cells (Lin+ cells)[13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h1b[13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C).

Choose factor column:

Take a hint from the table above




  logo